Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
This grant funds the preliminary identification of product leads and the development of prototypes for small molecules, biologics, and combination products.
About this program
The Catalyze grant program supports innovative projects focused on the early stages of product development for small molecules, biologics, and combination products. This funding opportunity is designed for researchers and organizations aiming to identify promising product leads and create prototypes that can advance to later stages of development. The program encourages collaboration among various stakeholders in the healthcare and pharmaceutical sectors to foster innovation and expedite the path to market for new therapies. Eligible applicants include academic institutions, small businesses, and nonprofit organizations engaged in research and development. The grant aims to facilitate the transition from concept to prototype, providing essential resources for teams working on groundbreaking solutions in the healthcare space. By supporting early-stage projects, the program seeks to enhance the pipeline of new products that can address unmet medical needs and improve patient outcomes.
Eligibility
Eligible applicants include academic institutions, small businesses, and nonprofit organizations engaged in research and development.